Clinical trial Recruiting at 2 sites Interventional Ages 18 to 90

Comparing ultrasound and CT-guided lung biopsies for diagnosing lung lesions

Official title: A Prospective, Randomized, Multicentric and Single-blinded Study on Accuracy and Safety of Ultrasound (US) Guided Percutaneous Needle Biopsy of Peripheral Lung Lesion Compared With Computed TomogrAphy (CT) Guided Needle Biopsy

Run by University Hospital of Ferrara · NCT06412289 · Data updated 2026-11-12

This study is testing whether ultrasound-guided lung biopsies are better or safer than CT-guided biopsies for diagnosing lung lesions in patients.

More Peripheral Lung Lesions trials

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment236 (estimated)
SponsorUniversity Hospital of Ferrara
Academic / other
Drugs / interventionsradiation
Locations2 sites (Ferrara and 1 other locations)
StatusRecruiting
StartedMarch 8, 2024
Main results expectedApril 30, 2026
Study endsOctober 31, 2026
Registry record updatedDecember 6, 2024
Trial IDNCT06412289 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old with peripheral pulmonary lesions that are adherent to the thoracic wall as indicated by CT scans.

Probably not a fit

Patients with terminal neoplastic diseases, severe organ failure, or those unable to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to compare the diagnostic accuracy of ultrasound-guided percutaneous lung biopsies with CT-guided biopsies in patients with peripheral lung lesions. It is a prospective randomized single-blind multicenter interventional study that will assess not only the accuracy of these two methods but also the onset of complications, exposure to ionizing radiation, patient comfort, and the duration of the procedures. The goal is to determine which method provides a safer and more effective means of diagnosing lung lesions, particularly given the increasing incidence of such lesions due to enhanced imaging techniques.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic methods for lung lesions, reducing complications and enhancing patient comfort.

How similar studies have gone: Previous studies have shown varying success with similar diagnostic approaches, but this specific comparison of ultrasound versus CT guidance is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willingness and ability to provide free and informed consent. Age older then 18 years old.
* Peripheric pulmonary lesions adherent to the thoracic wall in CT scans with indication to typing

Exclusion Criteria:

* Inability to provide free and informed consent, in the absence of an available legal guardian.
* Age younger then 18 years old.
* Terminal neoplastic diseases/ palliative care patients.
* Patients with one lung, anatomical of functional.
* Severe non-treatable blood clothing disfunctions.
* Severe organ failure (pulmonary, renal, hepatic or cardiac).
* Women in state of pregnancy.

Where it's running

  • UO Pneumologia AOSP-AUSL
    Ferrara, Italy
    Recruiting
  • UOC Pneumologia - Azienda ospedaliera A. Cardarelli
    Naples, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.